- Home
- Publications
- Publication Search
- Publication Details
Title
CDK7 inhibitors as anticancer drugs
Authors
Keywords
-
Journal
CANCER AND METASTASIS REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-09
DOI
10.1007/s10555-020-09885-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small-molecule targeting of brachyury transcription factor addiction in chordoma
- (2019) Tanaz Sharifnia et al. NATURE MEDICINE
- CDK7 inhibitor suppresses tumor progression through blocking the cell cycle at the G2/M phase and inhibiting transcriptional activity in cervical cancer
- (2019) Shanshan Zhong et al. OncoTargets and Therapy
- Targeting super-enhancer-driven oncogenic transcription by CDK7 inhibition in anaplastic thyroid cancer
- (2019) Xinyi Cao et al. THYROID
- THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer
- (2019) Ping Lu et al. ONCOGENE
- Aberrant super‐enhancer landscape in human hepatocellular carcinoma
- (2019) Felice Ho‐Ching Tsang et al. HEPATOLOGY
- Discovery and characterization of SY-1365, a selective, covalent inhibitor of CDK7
- (2019) Shanhu Hu et al. CANCER RESEARCH
- The covalent CDK7 inhibitor THZ1 potently induces apoptosis in multiple myeloma cells in vitro and in vivo
- (2019) Yu Zhang et al. CLINICAL CANCER RESEARCH
- Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma
- (2019) Yun Jung Choi et al. Scientific Reports
- Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
- (2019) Bowen Sun et al. ONCOGENE
- ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942
- (2019) Georgina P. Sava et al. ONCOGENE
- CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263
- (2019) Tianlu Huang et al. Cell Death & Disease
- CDK7 inhibition suppresses Castration-Resistant Prostate Cancer through MED1 inactivation
- (2019) Reyaz Ur Rasool et al. Cancer Discovery
- A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells
- (2019) Chiara Ghezzi et al. Nature Communications
- CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer
- (2019) Hua Zhang et al. CANCER CELL
- CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus
- (2019) Yong Suk Cho et al. GENES & DEVELOPMENT
- Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
- (2018) Rinath Jeselsohn et al. CANCER CELL
- High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma
- (2018) Philip Eliades et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
- (2018) Hetal Patel et al. MOLECULAR CANCER THERAPEUTICS
- The essential and multifunctional TFIIH complex
- (2018) Jenna K. Rimel et al. PROTEIN SCIENCE
- Inhibition of cyclin-dependent kinase 7 suppresses human hepatocellular carcinoma by inducing apoptosis
- (2018) Liqiang Zhong et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
- (2018) Adam D. Durbin et al. NATURE GENETICS
- Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma
- (2018) Lei Jiang et al. PATHOLOGY
- CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo
- (2018) Wei Meng et al. Cancer Management and Research
- Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer
- (2017) Zhenfeng Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Inhibitors of cyclin-dependent kinases as cancer therapeutics
- (2017) Steven R. Whittaker et al. PHARMACOLOGY & THERAPEUTICS
- THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
- (2017) Florencia Cayrol et al. Nature Communications
- Human TFIIH Kinase CDK7 Regulates Transcription-Associated Chromatin Modifications
- (2017) Christopher C. Ebmeier et al. Cell Reports
- Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors
- (2017) Sampada Kalan et al. Cell Reports
- Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
- (2017) S A Greenall et al. Oncogenesis
- Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer
- (2016) H. Patel et al. CLINICAL CANCER RESEARCH
- Upregulation of CDK7 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis
- (2016) Qiuhong Wang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Upregulation of cyclin-dependent kinase 7 and matrix metalloproteinase-14 expression contribute to metastatic properties of gastric cancer
- (2016) Ghodratolah Naseh et al. IUBMB LIFE
- Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
- (2016) Tinghu Zhang et al. Nature Chemical Biology
- Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
- (2016) A Harrod et al. ONCOGENE
- PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma
- (2016) Sujie Ni et al. TUMOR BIOLOGY
- Selective CDK7 inhibition with BS-181 suppresses cell proliferation and induces cell cycle arrest and apoptosis in gastric cancer
- (2016) Bo-Yong Wang et al. Drug Design Development and Therapy
- Structural and Functional Analysis of the Cdk13/Cyclin K Complex
- (2016) Ann Katrin Greifenberg et al. Cell Reports
- CDK7 and miR-210 Co-regulate Cell-Cycle Progression of Neural Progenitors in the Developing Neocortex
- (2016) Aisha I. Abdullah et al. Stem Cell Reports
- A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations
- (2015) Corina Hutterer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
- (2015) Yubao Wang et al. CELL
- Characterization of Human Cyclin-Dependent Kinase 12 (CDK12) and CDK13 Complexes in C-Terminal Domain Phosphorylation, Gene Transcription, and RNA Processing
- (2015) Kaiwei Liang et al. MOLECULAR AND CELLULAR BIOLOGY
- Architecture of the Human and Yeast General Transcription and DNA Repair Factor TFIIH
- (2015) Jie Luo et al. MOLECULAR CELL
- THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing
- (2015) Kyle A. Nilson et al. MOLECULAR CELL
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
- (2014) Camilla L. Christensen et al. CANCER CELL
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
- (2014) Edmond Chipumuro et al. CELL
- Cyclin-Dependent Kinase 7 Controls mRNA Synthesis by Affecting Stability of Preinitiation Complexes, Leading to Altered Gene Expression, Cell Cycle Progression, and Survival of Tumor Cells
- (2014) T. W. R. Kelso et al. MOLECULAR AND CELLULAR BIOLOGY
- TFIIH Phosphorylation of the Pol II CTD Stimulates Mediator Dissociation from the Preinitiation Complex and Promoter Escape
- (2014) Koon Ho Wong et al. MOLECULAR CELL
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
- (2014) Nicholas Kwiatkowski et al. NATURE
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Kin28 regulates the transient association of Mediator with core promoters
- (2014) Célia Jeronimo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The structure and substrate specificity of human Cdk12/Cyclin K
- (2014) Christian A. Bösken et al. Nature Communications
- Control of Transcriptional Elongation
- (2013) Hojoong Kwak et al. Annual Review of Genetics
- Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance
- (2013) M Kaliszczak et al. BRITISH JOURNAL OF CANCER
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- The CDK-activating kinase Cdk7
- (2013) Miriam Merzel Schachter et al. CELL CYCLE
- A Cdk7-Cdk4 T-Loop Phosphorylation Cascade Promotes G1 Progression
- (2013) Miriam Merzel Schachter et al. MOLECULAR CELL
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- ARCH domain of XPD, an anchoring platform for CAK that conditions TFIIH DNA repair and transcription activities
- (2013) W. Abdulrahman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CDK4 T172 Phosphorylation Is Central in a CDK7-Dependent Bidirectional CDK4/CDK2 Interplay Mediated by p21 Phosphorylation at the Restriction Point
- (2013) Xavier Bisteau et al. PLoS Genetics
- Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion
- (2012) Miguel Ganuza et al. EMBO JOURNAL
- A Universal RNA Polymerase II CTD Cycle Is Orchestrated by Complex Interplays between Kinase, Phosphatase, and Isomerase Enzymes along Genes
- (2012) Alain R. Bataille et al. MOLECULAR CELL
- Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II
- (2012) Stéphane Larochelle et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- TFIIB dephosphorylation links transcription inhibition with the p53-dependent DNA damage response
- (2012) J. Shandilya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC- -mediated signaling cascade in glioblastoma
- (2011) S. R. Desai et al. CARCINOGENESIS
- A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma
- (2011) Prajit Pillai et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process
- (2010) Pierre Chymkowitch et al. EMBO JOURNAL
- Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies
- (2010) Christophe Le Tourneau et al. EUROPEAN JOURNAL OF CANCER
- CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1
- (2010) B. Bartkowiak et al. GENES & DEVELOPMENT
- Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
- (2010) Wei-Gang Tong et al. JOURNAL OF CLINICAL ONCOLOGY
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- p53 Research: The Past Thirty Years and the Next Thirty Years
- (2010) D. Lane et al. Cold Spring Harbor Perspectives in Biology
- SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
- (2009) Andrew Conroy et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
- (2009) S. Ali et al. CANCER RESEARCH
- TFIIH-Associated Cdk7 Kinase Functions in Phosphorylation of C-Terminal Domain Ser7 Residues, Promoter-Proximal Pausing, and Termination by RNA Polymerase II
- (2009) K. Glover-Cutter et al. MOLECULAR AND CELLULAR BIOLOGY
- TFIIH Kinase Places Bivalent Marks on the Carboxy-Terminal Domain of RNA Polymerase II
- (2009) Md. Sohail Akhtar et al. MOLECULAR CELL
- Nucleotide Excision Repair Driven by the Dissociation of CAK from TFIIH
- (2008) Frédéric Coin et al. MOLECULAR CELL
- Distinct Activation Pathways Confer Cyclin-Binding Specificity on Cdk1 and Cdk2 in Human Cells
- (2008) Karl A. Merrick et al. MOLECULAR CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now